EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of an immune-related gene signature applying Ridge method for improving immunotherapy responses and clinical outcomes in lung adenocarcinoma

Zhen Chen, Yongjun Zhang

PeerJ · 2025

DOI: 10.7717/peerj.19121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von Zhen Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms, Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lung adenocarcinoma (LUAD) is a major cause of cancer mortality. Considering the critical role of tumor infiltrating lymphocytes in effective immunotherapy, this study was designed to screen molecular markers related to tumor infiltrating cells in LUAD, aiming to improve immunotherapy response during LUAD therapy.

Methods

The ConsensusClusterPlus method was used for clustering immune molecular subtypes of LUAD. Immune cell infiltration and immunotherapeutic potential in each subtype was evaluated employing single-sample gene set enrichment analysis (ssGSEA), Tumor Immune Dysfunction and Exclusion (TIDE), and Immunophenoscore (IPS). Immune-related co-expression modules were classified by weighted gene co-expression network analysis (WGCNA) analysis. The sequencing data of immune-related genes were comprehensively analyzed by introducing a new computational framework and 10 machine learning algorithms (a total of 101 combinations) to determine the prognostic genes, which were further combined to develop an immune prognostic signature (IMMPS) using the stepCox and Ridge methods. The expression of the signature genes was validated by quantitative real-time PCR (qRT-PCR).

Results

Samples from The Cancer Genome Atlas dataset (TCGA-LUAD) were divided into two subtypes (immunosuppressive subgroup C1 and immune-activated subgroup C2); notably, the C2 subgroup was more likely to benefit from immunotherapy ( p < 0.05). An IMMPS developed based on seven immune infiltrating cell-related genes ( SEMA7A, EFHD2, CHST11, SLC24A4, MAL, JCHAIN , and SCARF1 ) could accurately predict the overall survival of LUAD in five LUAD cohorts, with an average C-index higher than 0.69. LUAD patients with a low IMMPS value had a higher immune cell infiltration ( p < 0.05). In addition, the IMMPS exhibited better prediction performance in comparison to 154 published gene signatures, suggesting that the IMMPS was an independent prognostic risk factor for evaluating the overall survival of LUAD patients. Since BTNL9 was the most relevant immune checkpoint gene, in vitro experiment showed that the expression of the seven key genes ( SEMA7A, EFHD2, CHST11, SLC24A4, MAL, JCHAIN , and SCARF1 ) in LUAD cell lines was consistent with that in normal lung epithelial cells after inhibiting BTNL9 expression ( p < 0.05).

Conclusions

Our results contributed to a better understanding of immunological characteristics of LUAD. The IMMPS could serve as a promising tool for improving the clinical outcome of patients suffering from LUAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsImmunotherapyHumansPrognosisBiomarkers, TumorGene Expression Regulation, NeoplasticGene Expression ProfilingFemaleMaleLymphocytes, Tumor-InfiltratingTranscriptome

Stichwörter der Autor:innen

Computational biology and bioinformaticsImmunologyImmunotherapyLung adenocarcinomaMolecular biology

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
  • Department of Cardiothoracic Surgery, Xiangyang Central Hospital, Xiangyang, China.

Zitieren

APA

Chen, Z., & Zhang, Y. (2025). Development of an immune-related gene signature applying Ridge method for improving immunotherapy responses and clinical outcomes in lung adenocarcinoma. PeerJ. https://doi.org/10.7717/peerj.19121

Vancouver

Chen Z, Zhang Y. Development of an immune-related gene signature applying Ridge method for improving immunotherapy responses and clinical outcomes in lung adenocarcinoma. PeerJ. 2025. doi:10.7717/peerj.19121

BibTeX
@article{Chen2025,
  author = {Chen, Zhen and Zhang, Yongjun},
  title = {Development of an immune-related gene signature applying Ridge method for improving immunotherapy responses and clinical outcomes in lung adenocarcinoma},
  journal = {PeerJ},
  year = {2025},
  doi = {10.7717/peerj.19121}
}
Kostenlos starten →